Chargement en cours...
Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been demonstrated to improve responses and clinical outcomes significantly in patients with advanced non-small-cell lung cancer (NSCLC). In retrospective subgroup analyses of several studies, patients with Asian ethnicity...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3928465/ https://ncbi.nlm.nih.gov/pubmed/24611018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S45096 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|